Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular DystrophyWe are pleased to announce our collaboration with Parent Project Muscular Dystrophy to facilitate swift access to the trial for qualifying individuals. This partnership aims to ensure that eligible patients have timely entry into the program.
